متابعة
Peter Gennemark
Peter Gennemark
Researcher at AstraZeneca
بريد إلكتروني تم التحقق منه على astrazeneca.com
عنوان
عدد مرات الاقتباسات
عدد مرات الاقتباسات
السنة
Integrative model of the response of yeast to osmotic shock
E Klipp, B Nordlander, R Krüger, P Gennemark, S Hohmann
Nature biotechnology 23 (8), 975-982, 2005
5342005
Models from experiments: combinatorial drug perturbations of cancer cells
S Nelander, W Wang, B Nilsson, QB She, C Pratilas, N Rosen, ...
Molecular systems biology 4 (1), 216, 2008
2112008
Network modeling of the transcriptional effects of copy number aberrations in glioblastoma
R Jörnsten, T Abenius, T Kling, L Schmidt, E Johansson, TEM Nordling, ...
Molecular systems biology 7 (1), 486, 2011
1092011
Structural and functional characterization of a specific antidote for ticagrelor
A Buchanan, P Newton, S Pehrsson, T Inghardt, T Antonsson, ...
Blood, The Journal of the American Society of Hematology 125 (22), 3484-3490, 2015
972015
An oral antisense oligonucleotide for PCSK9 inhibition
P Gennemark, K Walter, N Clemmensen, D Rekić, CAM Nilsson, ...
Science Translational Medicine 13 (593), eabe9117, 2021
882021
Efficient algorithms for ordinary differential equation model identification of biological systems
P Gennemark, D Wedelin
IET Systems Biology 1 (2), 120-129, 2007
682007
Unlock the thermogenic potential of adipose tissue: pharmacological modulation and implications for treatment of diabetes and obesity
XR Peng, P Gennemark, G O’Mahony, S Bartesaghi
Frontiers in endocrinology 6, 174, 2015
662015
Benchmarks for identification of ordinary differential equations from time series data
P Gennemark, D Wedelin
Bioinformatics 25 (6), 780-786, 2009
642009
PPARγ and PPARα synergize to induce robust browning of white fat in vivo
T Kroon, M Harms, S Maurer, L Bonnet, I Alexandersson, A Lindblom, ...
Molecular metabolism 36, 100964, 2020
592020
Discovery of (3-(4-(2-oxa-6-azaspiro [3.3] heptan-6-ylmethyl) phenoxy) azetidin-1-yl)(5-(4-methoxyphenyl)-1, 3, 4-oxadiazol-2-yl) methanone (AZD1979), a melanin concentrating …
A Johansson, C Lofberg, M Antonsson, S von Unge, MA Hayes, R Judkins, ...
Journal of Medicinal Chemistry 59 (6), 2497-2511, 2016
552016
A simple mathematical model of adaptation to high osmolarity in yeast
P Gennemark, B Nordlander, S Hohmann, D Wedelin
In silico biology 6 (3), 193-214, 2006
542006
Hemostatic effects of the ticagrelor antidote MEDI2452 in pigs treated with ticagrelor on a background of aspirin
S Pehrsson, KJ Johansson, A Janefeldt, AS Sandinge, S Maqbool, ...
Journal of Thrombosis and Haemostasis 15 (6), 1213-1222, 2017
282017
Distribution and biotransformation of therapeutic antisense oligonucleotides and conjugates
L Weidolf, A Björkbom, A Dahlen, M Elebring, P Gennemark, M Hölttä, ...
Drug discovery today 26 (10), 2244-2258, 2021
232021
A modeling approach for compounds affecting body composition
P Gennemark, R Jansson-Löfmark, G Hyberg, M Wigstrand, D Kakol-Palm, ...
Journal of pharmacokinetics and pharmacodynamics 40, 651-667, 2013
212013
Requirements for multi-level systems pharmacology models to reach end-usage: the case of type 2 diabetes
E Nyman, YJW Rozendaal, G Helmlinger, B Hamrén, MC Kjellsson, ...
Interface focus 6 (2), 20150075, 2016
202016
Formal representation of the high osmolarity glycerol pathway in yeast
C Kühn, KVS Prasad, E Klipp, P Gennemark
Genome Informatics 2009: Genome Informatics Series Vol. 22, 69-83, 2010
182010
Effects of a novel potent melanin‐concentrating hormone receptor 1 antagonist, AZD1979, on body weight homeostasis in mice and dogs
K Ploj, L Benthem, D Kakol‐Palm, P Gennemark, L Andersson, M Bjursell, ...
British Journal of Pharmacology 173 (18), 2739-2751, 2016
172016
Systems biology reveals uncoupling beyond UCP1 in human white fat-derived beige adipocytes
E Nyman, S Bartesaghi, R Melin Rydfalk, S Eng, C Pollard, P Gennemark, ...
NPJ systems biology and applications 3 (1), 29, 2017
162017
Hybrid modelling for stroke care: Review and suggestions of new approaches for risk assessment and simulation of scenarios
T Herrgårdh, VI Madai, JD Kelleher, R Magnusson, M Gustafsson, ...
NeuroImage: Clinical 31, 102694, 2021
152021
Quantifying and communicating uncertainty in preclinical human dose‐prediction
M Sundqvist, A Lundahl, MB Någård, U Bredberg, P Gennemark
CPT: pharmacometrics & systems pharmacology 4 (4), 243-254, 2015
152015
يتعذر على النظام إجراء العملية في الوقت الحالي. عاود المحاولة لاحقًا.
مقالات 1–20